Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively

Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein

(2011) Hidenori Toyoda et al.   CANCER SCIENCE

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Clinical Advantage of Highly Sensitive On-Chip Immunoassay for Fucosylated Fraction of Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma

(2010) Yasushi Tamura et al.   DIGESTIVE DISEASES AND SCIENCES

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

(2010) Masao Omata et al.   Hepatology International

Surveillance algorithm and diagnostic algorithm for hepatocellular carcinoma

(2010)   HEPATOLOGY RESEARCH

Automated immunoassay system for AFP–L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis

(2009) Chiaki Kagebayashi et al.   ANALYTICAL BIOCHEMISTRY

High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma

(2009) Masahiro Kobayashi et al.   CANCER

Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment

(2009) Yasushi Tamura et al.   DIGESTIVE DISEASES AND SCIENCES

α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

(2009) Jorge A. Marrero et al.   GASTROENTEROLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

(2008) Hidenori Toyoda et al.   JOURNAL OF HEPATOLOGY